stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Walgreens Boots Alliance, Inc.

United States Β· Privately owned

Walgreens runs drugstores and pharmacy counters that sell prescription drugs and health and beauty products to U.S. consumers.

Walgreens is the corner drugstore many Americans grew up with. You go there to pick up a prescription, grab shampoo, buy a birthday card, or get a flu shot. Its stores sit in neighborhoods across the country, and the pharmacy counter in the back is the heart of the business: it fills prescriptions, gives vaccines, and answers health questions for people who may not have a regular doctor.

The money mostly comes from filling prescriptions, paid largely by insurance companies and government health programs rather than by you directly at the register. The front of the store β€” the shelves of toothpaste, cosmetics, and snacks β€” brings people in and adds sales, but the pharmacy is what keeps the lights on. Walgreens also runs one of the biggest pharmacy chains in Britain, and it sells health and beauty products under its own brands, which tend to carry better margins than the big national labels. For years Walgreens was a public company whose shares traded on Nasdaq under the ticker WBA. That changed: the company was taken private in 2025, with ownership split between the private equity firm Sycamore Partners and the company's own founding family, the Walgreens family. So it no longer trades on a public stock exchange, and you can't buy a share of it the way you buy Apple or Coca-Cola.


The business faces real pressure. Rival chains like CVS Health compete hard for the same customers, and online sellers keep pulling everyday shopping away from physical stores. Drug reimbursements from insurers have gotten tighter, squeezing the profit on each prescription. That is a big part of why Walgreens sold off its stake in the wholesale drug distributor AmerisourceBergen and why it ended up in private hands β€” the new owners are betting they can fix the stores and the pharmacy economics away from the quarterly spotlight of public markets.

Saved answer Β· last researched 15 Nov 2026